{"id":"badc401f-0c44-458a-8c9d-91d8dddcfd4f","name":"Cognixion","slug":"cognixion","description":"Cognixion is a Santa Barbara-based neurotechnology company developing non-invasive brain-computer interface technology integrated with augmented reality. Its [Cognixion ONE Axon-R](/models/cognixion-ar-bci-headset) headset combines BCI, AI, and AR for communication in patients with ALS and severe motor impairment. FDA Breakthrough Device Designation (May 2023). Clinical trial launched for late-stage ALS. $25M raised to date. Named Wearable & Implantable Technology of the Year at MedTech World 2026.","status":null,"founded":null,"hq":"Santa Barbara, California, USA","hqLat":null,"hqLng":null,"hqGeocodedAt":null,"hqAddress":null,"hqPrecision":null,"website":"https://www.cognixion.com","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[],"keyFacts":[],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:26:45.318Z","updatedAt":"2026-08-08T22:51:48.354Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/cognixion","url":"https://registry.deploy.report/companies/cognixion","name":"Cognixion","description":"Cognixion is a Santa Barbara-based neurotechnology company developing non-invasive brain-computer interface technology integrated with augmented reality. Its [Cognixion ONE Axon-R](/models/cognixion-ar-bci-headset) headset combines BCI, AI, and AR for communication in patients with ALS and severe motor impairment. FDA Breakthrough Device Designation (May 2023). Clinical trial launched for late-stage ALS. $25M raised to date. Named Wearable & Implantable Technology of the Year at MedTech World 2026.","identifier":"badc401f-0c44-458a-8c9d-91d8dddcfd4f","address":"Santa Barbara, California, USA","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"claimed-not-verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":0,"primary_source_types":[]}}}